Naason Science ramps up services in response to COVID-19 global outbreak.

Naason Science
Naason Science
  • Home
  • Research
    • Preclinical Research
    • Neurology Models
    • Pain Models
    • Oncology Models
    • Ophthalmology Models
    • Orthopedic Models
    • Metabolic Disease Models
    • Psychiatric Models
  • Discovery
    • Areas of Expertise
    • Capabilities
  • News
  • Careers
    • Careers
    • Naason Team
  • Contact
  • Portal
  • More
    • Home
    • Research
      • Preclinical Research
      • Neurology Models
      • Pain Models
      • Oncology Models
      • Ophthalmology Models
      • Orthopedic Models
      • Metabolic Disease Models
      • Psychiatric Models
    • Discovery
      • Areas of Expertise
      • Capabilities
    • News
    • Careers
      • Careers
      • Naason Team
    • Contact
    • Portal
  • Home
  • Research
  • Discovery
  • News
  • Careers
  • Contact
  • Portal

Ophthalmology Models

Rat Model for Dry Eye Disease

Naason Science is offering Efficacy Evaluation of Compounds in a Rat Model of Dry Eye Disease. The objective of the model to investigate whether the compound has an anti-dry eye syndrome effect in a Rat Model of Dry Eye Disease induced by Extraorbital Lacrimal Gland Excision (ELGE).


In our pilot study ELGE surgery was performed after the body weight was measured on day 1. The test substance was administered in eyeballs and treatments were continued for 14 days after 1 week of ELGE surgery. The Schirmer test on the rats’ both left and right eyes were carried out to measure basal and reflective tear secretion. The efficacious effects of compounds were compared also to Xiidra® (Shire US Inc, USA) as FDA approved eye drop syndrome agent.


For more information about our Rat Model for Dry Eye Disease please contact info@naasonscience.com.

preclinical research
contract research
preclinical
drug discovery
drug development
Animal Models
amd

Age-related Macular Degeneration (AMD)

Age-related macular degeneration (AMD), is a medical condition which may result in blurred or no vision in the center of the visual field due to damage to the macula of the retina. There is no cure or treatment that returns vision already lost and medication works only in slow down progression of disease. AMD is classified as Wet form and dry form.


Naason Science is offering Efficacy Evaluation of a Compound in a Rat Model of Aged Macular Degeneration induced by blue light exposure. 


For more information about our Rat Model for AMD please contact info@naasonscience.com. 


image438

For more information please

Contact us

© 2021 Naason Science Inc. All rights reserved.

  • Home
  • Preclinical Research
  • Areas of Expertise
  • News
  • Careers
  • Contact
  • Privacy & Terms

Welcome to Naason Science website!

Our website uses cookies. By continuing to use this site, you accept our use of cookies.

DeclineAccept